In the present paper we report on a case of oculo-auriculo-vertebral spectrum presenting fluorescence in situ hybridization and comparative genomic hybridization tests negative, hypotonia of some branchiomeric muscles (with velo-pharyngeal insufficiency, dysphagia and nasal voice) and non-branchiomeric muscles (with strabismus and limb hypotrophy). On the basis of the left quadriceps muscle biopsy, showing anisometry and prevalence of type 1 fibers, and on literature data, we underline the relevance of TBX1 gene (regulator of neural crest cells and activator of myogenic factors in branchiomeric muscles development) and of PAX3 gene (present in neural crest, inducing migration of these cells and reported in non-branchiomeric muscles). We conclude that the case of OAVS presented a generalized myopathy and we hypothesize that a cluster of genes strictly neural crest cells related, including TBX1 and PAX3, may be responsible of the branchiomeric and non-branchiomeric myopathy; alternatively, a regulatory mechanism abnormally common to OAVS and velo-cardio-facial syndrome could be present.
Introduction
In oculo-auriculo-vertebral spectrum (OAVS), 1 hypotonia, muscular hypotrophy, and hypernasal voice were repeteadly reported. 1, 2 In the personal case of OAVS with these symptoms reported below, the a nonbranchiomeric muscle (left quadriceps) biopsy showed generalized muscle disease. This case emphasizes the importance and complexity of the myopathy in OAVS.
by slow decrease. Lactate dehydrogenase (LDH) was intermittently high (294-519 IU/dL) (nv 84-361). Fluorescence in situ hybridization (FISH) and comparative genomic hybridization (CGH) tests were negative. Electromyography showed some motor unit potentials, but with reduced duration; motor was amplitude normal.
At somatosensory evoked potentials (lower limbs), cortical components of somatosensory conduction were not identifiable; peripheral components were normal.
Muscular biopsy (left quadriceps m.) (at 13 years of age) showed fibre anisomery with normal, hypotrophic and numerous hypertrophic fibres. No degeneration signs were present, there was no pathologic accumulation of glycides nor of lipids on oil ed and Periodic acid-Schiff staining. On Gomori trichrome stain, no ragged red fibres were recorded; nicotinamide adenine dinucleotide, succinate dehydrogenase, cytochrome c oxidase, phosphorylase, phosphofructokinase, ATP-ase stains was normal. On ATP-ase stain there was a clear prevalence of first type fibres (oxidative fibres) (in normal children, from 30 months to adult age, an equal proportion of type 1 and type 2 fibres was reported by Dubowitz). 3 To sum up, signs of abnormality in muscles of facial expression, of deglutition and phonation with nasal speech and of limbs were present in our case of OAVS. The gaps in velopharingeal sphincter were probably due both to velar and pharyngeal muscles, necessary for velo-pharyngeal closure, and to hypotonia and hypoplasia. 4 This condition may be consequent to OAVS malformative complex involving the facial structures and also other parts of the body. 2 Palpebral ptosis due to hyposthenia of levator palpebrae muscle, pharynx constrictor and levator velipalatini muscles, and limb muscle hypotonia and hypotrophia were clinical signs of myopathy, confirmed by hyperlactacidemia and elevated LDH. 2 We may conclude that, in our patient, myopathy affected branchiomeric and nonbranchiomeric muscles (quadriceps m.) ( Table 1) .
Discussion
Oculo-auriculo-vertebral spectrum is characterized by cardinal features of hemifacial microsomia, eye, ear, face and vertebral abnormalities, 1 sometime associated with multiple malformations. 1 Goldenhar syndrome, a typical neurocristopathy, [5] [6] is included in OAVS.
The OAVS syndrome present multiple etiologies. It was frequently observed in children born from diabetic mothers. 7 In some cases, OAVS affected individuals in subsequent generations with dominant autosomal or recessive inheritance. [8] [9] [10] In these families, as in that of our patient, some members may present with isolated features. The disease occurs in monozygotic twins. These observations confirm that genetic factors can increase susceptibility to OAVS. 11 The estimate risk of recurrence of OAVS in these families is 1-2%. 1 The disease is considered a neurocristopathy. 5, [6] [7] [8] [9] [10] The alterations of facial osseus, cartilagineous, vascular and peripheral nerve structures are attributed to aberrant migration to the first and second branchial arches during 4 th and 5 th embryonic weeks and/or integration with tissues of neural crest cells (NCC). 10 In NCC, specific expression of some homeobox genes (MSX, PAX3) 11, 12 and some factors (FGF8, FGF10) are important for the differentiation of ectodermal and mesenchymal tissues in the first and second branchial arches, which leads to various important structures. In pathological conditions, an abnormality of NCC leads to alterations of the developing ear and eye (during the 4 th , 5 th and 6 th week). [10] [11] [12] [13] In OAVS, the clinical variability is high also in familial cases, but no specific gene for OAVS was demonstrated and the disease was attributed to a contiguous gene dysfunction. 14 Epigenetic factors as disruption of BAX were also advocated.
The generalized malformations present in this condition suggest a disorder of blastogenesis during the first 28 days of embryological life, when body axes are formed and cardio-angiogenesis, meso-nephrogenesis, neurulation and somites arise. 10 Neurulation with migration of NCC is essential for the development of branchial arches, from which face and neck structures derive.
In humans, five pharyngeal arches (i.e. a series of transitory cartilagineous structures surrounding the pharynx) arise in the lateral side of the head during the 4 th and 5 th weeks of embryological life. Each arch presents endodermal, ectodermal and mesodermal cells, and NCCderived cells. The endoderm originates the limiting epithelium, the thyroid, the parathyroids, and the thymus; the ectoderm originates the epidermal structure; the paraxial and anterior occipital mesoderms originate the mesodermal core of every arch which is populated by NCC contributing to mesenchime which in turn gives rise to connective, cartilagineous, and bone tissues of the head, face, and neck. 5, [6] [7] [8] [9] [10] The mesodermal cells of pharyngeal arches migrate laterally in the pharyngeal region, giving rise to the branchiomeric skeletal muscles of the head and neck, [15] [16] [17] i.e. the muscles of mastication, deriving from the 1 st arch, the muscles of facial expression, deriving from the 2 nd arch, the muscle of the pharynx and the intrinsic muscle of the larynx, originating from the 3 rd and 4 th -5 th arches (Table 1) . 15, 16 The non-branchiomeric muscles of the head include that muscles derived from the most anterior part of the paraxial mesoderm: extraocular muscles (medialis rectus, inferior rectus, inferior obliquus, levator palpebrae), tongue muscles originating in the anterior somites, and trunk and limb muscles, arising from somites.
Somites are spheres of epithelial cells adjacent to the neural tube and notochord; they become mesenchymal in the ventral part (sclerotome) from which the vertebrae arise, and persist in the dorsal part (dermomyotome), giving rise to skeletal muscles and dermis. The Shh gene, which stimulates somatic myogenesis in mouse, was demonstrated in floor plate notochord and in pharyngeal arches; 13 the neural tube and induce in association to Shh, trunk somatic myogenesis. 18 During embryological life, the muscle which first differentiates is the myotome, originated by signals of adjacent tissues (neural tube, notochord). The myogenic progenitor cells of the dermomyotome give rise to all non-branchiomeric skeletal muscles of the body (trunk and limb) 18 and to some head muscles. In the dermomyotome, some genes are expressed: dorsally, Pax7 and Pax3 pathways, which activate myogenic basic-helix loop helix regulatory factors (Basic HLHMRF), Myf5, MyoD and myogenin; ventrally, in sclerotome, Pax1 and Pax9. 18 Pax3 is required in embryonic skeletal myogenesis 19, 20 and in the developmental program regulating NCC. Pax3 is expressed in paraxial mesodermal [18] [19] [20] and neuroectodermal tissues, in epithelial somites, 21 and in mesoangioblasts, vessel-associated stem cells which may differentiate in skeletal muscles and other mesodermal tissues (smooth and cardiac muscles, bones, fat). Pax3 is found in dermomyotome (dorsal somite cells from which skeletal muscles derive) and is required for the migration of these cells outside the somites; subsequently, Pax3 activates the Myf5 gene in limbs and MyoD, Fgfr4 and Sprouty inhibitory genes. On Pax3 and Pax7 positive cells, originating from the central dermomyotome, depend the differentiation of mesoangioblasts in skeletal muscles and post-natal myogenesis. 20 In humans, PAX3 mutation causes the Waardenburg-Klein syndrome, a NCC disease with sensory, hearing, pigmentation and muscular defects. 22 In embryo, non-branchiomeric skeletal muscles development is regulated by the MyoD family of basic HLHMRF, first expressed in branchial arches. 4 Mice without Myf5 and Pax3 factors do not develop skeletal muscles of trunk and limbs but present normal head muscles. 4 Wnt signal stimulates myogenesis of the trunk but blocks that of the head. 4 Therefore, it is evident that branchiomeric muscle development is genetically regulated in a different manner compared to the nonbranchiomeric muscle. In humans, TBX1 (homologous to mouse Tbx1) plays a central role in initiating branchiomeric muscle development, 13, [22] [23] [24] directly and indirectly, via the activation of MYF5 and MYOD1 4 and the modulation of myogenic signals in surrounding NCC; abnormal development of these muscle might explain the swallowing difficulties present in our case. Tbx1 gene is expressed in mice in endoderm and mesoderm pharyngeal arches 13 during NCC migration. 24 It plays an important role in mandibular arches development by regulating NCC patterning; 4 it is expressed in adult skeletal muscles and in vertebral column. 24 In heterozygous Tbx1 +/-mice all first arch derived branchiomeric muscles are present including pharyngeal constrictor musculus, but they are absent in homozygous Tbx1 -/-mice, 4 a condition attributed to the low Tbx1 level.
In patients with velo-cardio-facial syndrome attributed to 22q11.2 microdeletion and haploinsufficiency of TBX1, Zim et al. 23 demonstrated that velo-pharingeal insufficiency with hypernasal speech and swallowing difficulty were due to hypotonia of velar and pharyngeal branchiomeric muscles, particularly the superior pharyngeal constrictor, necessary for pharyngeal closure. In these patients, TBX1 haploinsufficiency with reduced TBX1 levels may lead to pharyngeal hypotonia. [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] At muscular biopsy, superior pharyngeal constrictor muscle presented anisometry and a significantly greater proportion of type 1 (oxidative, with more mitochondria) fibres than in normal subjects. 23 These observation suggest the relevance of TBX1 in branchiomeric myogenesis. 23 In our case of OAVS, hypotonia observed at birth of non-branchiomeric rectus medialis musculus (with strabismus), of non-branchiomeric muscles as levator palpebrae (with ptosis), and foot muscles (with talipes valgus), suggest a congenital myopathy of non-branchiomeric muscles, with prevalence of type 1 oxidative fibers, more rich in mitochondria. Nasal speech and swallowing difficulties were attributed to velo-pharyngeal branchiomeric muscle insufficiency.
The association of NCC-derived facial structure abnormalities with branchiomeric muscle abnormalities may suggest a causative role of NCC regulatory genes (as TBX1) 4 possibly in association with other genes. 4 In our OAVS case, the cause of non-branchiomeric muscle hypotonia is unknown.
In patients with velo-cardio-facial syndrome due to TBX1 mutation (del 22q11.2), hypotonia of non-branchiomeric muscles (extraocular and limb muscles) and velopharyngeal hypotonia are present. 4 However, the pathophysiology of this condition has not been completely understood yet. 13 The non branchial arch phenotype in man can be explained by the expression pattern of haploinsufficiency of TBX1 in mesoderm and in sclerotome. 13 It was observed in patients with TBX1 (del 22q11.2) that TBX1 is expressed in sclerotome and in mesoderm, that myogenic regulatory factors (MRFs) expression is normal in non-branchiomeric muscles of limbs. Therefore, hypotonia in these muscles cannot be attributed to isolated TBX1 deficiency, but rather to environment or to a different gene background which can modify the effect of haploinsufficiency of gene with the deletion. 25 In the latter case, other genes may contribute to the myopathy of the non-branchiomeric muscles: i.e. NCC-related genes (MSX) 26 or genes regulating NCC (PAX3). 20, 21 In our case, the result of the biopsy of a non-branchiomeric muscle, similar to that performed by Zim in a velo-cardio-facial syndrome branchiomeric muscle, 23 suggests the relevance of the NCC regulatory genes (direct or indirect) or of NCC related genes. Negativity of FISH and CGH for a gene mutation cannot rule out the possible complex insertion of genes or minimal deletion(s), rearrangements and consequent haploinsufficiency of genes (as reported in TBX1 non deleted patients). 25 An activating factors to OAVS and velocardiofacial/Di George syndrome was recently hypothesized responsible of these conditions. 27 N o n -c o m m e r c i a l u s e o n l y
